|
|
||||||||
J Thorac Cardiovasc Surg 2002;124:105-112
© 2002 The American Association for Thoracic Surgery
Surgery for Congenital Heart Disease (CHD) |
From the Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland,a and University of Milan, Milan, Italy.b
Received for publication May 22, 2001. Revisions requested Aug 14, 2001; revisions received Sept 7, 2001. Accepted for publication Oct 22, 2001. Address for reprints: Antonio F. Corno, MD, FRCS, FECTS, Centre Hospitalier Universitaire Vaudois, 46 rue du Bugnon, CH 1011, Lausanne, Switzerland (E-mail: Antonio.Corno{at}chuv.hospvd.ch).
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
The progress in the perioperative management of pediatric patients with congenital heart defects has had a substantial effect on the outcome of surgical intervention, and a decreased mortality has been reported also for repair of complex congenital heart defects.
1,2 Nevertheless, there is a subset of children undergoing cardiac surgery with higher risk for either a prolonged or complicated postoperative course: cyanotic patients with preoperative exposure to chronic hypoxia.
3,4
Many experimental studies have been performed to evaluate the effects of hypoxia on the cardiovascular system, but most of them, including our own, concerned exposure to acute hypoxia.
5-7 Because it is evident that hypoxia produces long-term effects that could profoundly influence the myocardial metabolism and function,
3,8-12 we need studies with chronic hypoxia.
Currently, there are no models available that adequately mimic chronic perfusion of hearts with hypoxic blood. A common experimental model to evaluate the complex effects of chronic hypoxia on the cardiovascular system is raising animals in hypoxic or hypobaric chambers for extended periods of time, killing the animals, excising the hearts, and perfusing the hearts with oxygenated media. In this context, however, there are at least 2 instances in which the hearts may be suddenly reoxygenated prematurely, thereby undergoing reoxygenation injury.
13-16 First, the classic design of the hypoxic or hypobaric chamber usually does not allow for daily maintenance, and therefore during feeding, as well as during cleaning, the animals are exposed to room air, with subsequent intermittent reoxygenation. Second, the hearts are generally perfused with oxygenated media to obtain baseline values; this operation implies that reoxygenation injury occurs before the baseline hypoxic values are taken.
In our previous experimental studies with acute hypoxia we demonstrated that (1) the reoxygenation of hypoxic hearts impairs the ventricular function significantly more than after ischemia-reperfusion
6 and (2) the reoxygenation-reperfusion injury is much more severe in hypoxic than in ischemic hearts.
16 The results of our experimental studies were in agreement with the clinical observation that cyanotic patients with congenital heart defects are less tolerant to ischemia with respect to noncyanotic control subjects.
17
In this experimental research we used a newly designed hypoxic chamber system, preventing any premature accidental exposure to room air and hypoxic perfusion during the initial period. The myocardial metabolism and function were monitored during the first oxygenation after a 2-week period of continuous hypoxia. The aim of our study was to evaluate the systemic and cardiac effects of chronic hypoxia and the effects of the reoxygenation on hypoxic versus normoxic hearts.
| Methods |
|---|
|
|
|---|
Cages
The cages used in this study (Figure 1) were newly designed with the purpose of fully preventing the animals from experiencing any accidental exposure to room air (FIO2, 0.21) during their entire stay, including during feeding and cleaning operations. Transparent plastics cages (350 x 350 x 200 mm) were built for 2 animals each to accomplish this goal. Every cage was equipped with a 165-mm diameter window with a plastic sleeve (Nufer Medical, Gumligen, Switzerland). In addition, a hole was made in the cage to allow for insertion of an oxygen electrode (Servomex Oxygen Analyzer 570 A, Zurich, Switzerland). An additional precage was built with the same dimension of the cages but with 2 windows. All cages were flushed with gas containing 10% ± 0.1% oxygen (Carbagas, Lausanne, Switzerland). When a cage opening was required for regular cleaning and bed change or for operating on the animal, the precage was first flushed with the hypoxic gas, and then it was applied on the top of the cage, maintaining the 2 adjacent plastic sleeves. The operator could therefore clean the cage while avoiding animal exposure to room air. The oxygen level monitored by means of the oxygen electrode during the operation never increased by more than 1%. For animal operation, the animal was first transferred into the precage under hypoxic conditions, which was then accurately closed and moved to the site where hearts were perfused. The presence of 2 plastic sleeves allowed the operator to anesthetize the animal, weigh it, and excise the heart at the same oxygen level (10%) as that of the animals that lived inside the precage. The oxygen percentage monitored with the oxygen electrode during this phase never increased by more than 2%.
|
|
Measurements of myocardial function and metabolism
Myocardial performance was monitored with a LabView system (National Instruments, Austin, Tex) running on a personal computer. The measured parameters included left ventricular end-diastolic pressure (LVEDP), heart rate (HR), left ventricular developed pressure (LVDP), coronary perfusion pressure (CPP), and oxygen uptake (VO2), which was calculated from venous PO2 and coronary flow. The coronary vascular resistance was calculated as CPP-LVEDP per flow per gram of ventricle. Samples of the venous effluent were frozen at -80°C and later assayed for lactate by means of enzymatic methods with COBAS FARA II (Hoffman-La Roche, Basel, Switzerland) equipment.
Simultaneous measurements of lactate release and venous PO2, together with glucose as the only substrate, allows estimating the anaerobic and aerobic contributions to total adenosine triphosphate (ATP) turnover:
Lactate release + (6 x VO2)6
For this, we assumed the ATP/lactate ratio to be ±1.0 (glucose as substrate without significant glycogenolysis) and the ATP/oxygen ratio to be 6 (no mitochondrial uncoupling).
Experimental protocol
All hearts were subjected to 30 minutes of hypoxic perfusion with 15 mL/min coronary flow and 10% oxygen saturation. During the hypoxic period, the intraventricular balloon volume needed to increase the LVEDP from 0 to 10 mm Hg was measured. The balloon volume was kept constant throughout the rest of the experiment. After the hypoxic perfusion, hearts were reoxygenated for 30 minutes with the perfusion medium at 100% oxygen saturation. At the end of the perfusion, the hearts were weighed.
Statistics
Data are expressed as means ± SD.
| Results |
|---|
|
|
|---|
|
Myocardial function
Systolic function
During the hypoxic baseline perfusion, there was no difference between the 2 groups with regard to HR, LVDP, and HR x LVDP. During reoxygenation, HR and LVDP increased in both groups, but more in the normoxic group, leading to a significant difference (P < .05) between the 2 groups for the HR x LVDP product (Figure 3, A).
|
Myocardial metabolism
Although, during the hypoxic baseline period, the venous PO2 remained low in both groups, during reoxygenation, it was higher in hypoxic hearts, showing a significantly (P < .01) lower oxygen uptake in this group (Figure 4, A). During hypoxic baseline lactate production, lactate turnover and ATP turnover were higher in normoxic hearts (P < .0001, P < .0001, and P < .005, respectively; Figure 4
, B-D), whereas during reoxygenation, lactate was undetectable in both groups.
|
| Discussion |
|---|
|
|
|---|
Children with cardiac malformations are often cyanotic, and the surgical intervention for cyanotic congenital heart defects is hindered by greater mortality and morbidity than in the corresponding treatment in noncyanotic hearts.
4,17 This feature may arise from the injury induced by acute reoxygenation at the onset of cardiopulmonary bypass,
13-16,19 with free radicals as a major mediator in the hypoxia-reoxygenation injury.
13,16
Despite the fact that the vast majority of experimental studies, including ours,
5-7 have evaluated the effects of acute hypoxia on the cardiovascular system, within the last few years, an increasing number of studies concerned chronic hypoxia,
8,9,11,12,20 and it is now evident that hypoxia produces long-term effects that could profoundly influence the myocardial metabolism and function.
3,8-12
To perform the functional and metabolic evaluation, we used the conventional Langendorff model of the isolated perfused heart, with its well-known advantages and limits.
18 Recently, a very promising mathematic model to study the cardiovascular effects of hypoxia has been presented and validated.
21
Animal homeostasis
In this study exposure to normobaric chronic hypoxia induced profound changes in the blood oxygen transport characteristics. The selected FIO2 for chronic hypoxia would yield a PAO2 of 45 mm Hg, which is equivalent to 5500 m above sea level and not substantially different from the PAO2 of most children with cyanotic congenital heart defects. The increase in hematocrit values, hemoglobin concentration, and red blood cell count, common findings in all experimental and clinical studies with chronic hypoxia, is a well-known consequence of increased hypoxia-induced erythropoietin production.
20,22
Because all rats entered the protocol at 5 weeks of age, normoxic rats experienced physiologic net weight gain over 2 weeks (+102 ± 13 g). Despite unlimited access to food and water, hypoxia-induced deterioration was more powerful than the physiologic net weight gain in hypoxic rats, which underwent weight loss (-55 ± 9 g); this is similar to the situation seen in adult human subjects exposed to high altitude for variable periods and to that in children with cyanotic congenital heart defects. The weight change did not correlate with the amount of ingested food, indicating greater efficiency in food consumption in normoxic than in hypoxic animals.
12
The higher ratio between heart weight and body weight observed in hypoxic rats indicates ventricular hypertrophy, probably as a result of hypoxia-induced expression of several growth factors, including the vascular endothelial growth factor, as well as of increased systemic and vascular resistance caused by the higher hematocrit value.
23
Myocardial function
Although both systolic and diastolic functions were the same in the 2 groups during the hypoxic baseline period, the reoxygenation induced different behavior. The hearts from hypoxic animals appear more vulnerable than normoxic hearts to a sudden increase of oxygen supply after a short period of oxygen shortage. Possibly the decreased ventricular compliance and impaired contractility are due to the hypoxia-induced calcium load, which is further increased by the sudden reoxygenation. In this regard, we demonstrated, in previous studies, the occurrence of reoxygenation injury within the first few minutes of full oxygen readmission,
15 as well as the possibility of reducing the reoxygenation injury by reducing the rate of reoxygenation,
14 as routinely performed in our clinical practice.
24
Reduced coronary vascular resistance in hypoxic hearts during the hypoxic perfusion, as well as during the reoxygenation, shows that chronic hypoxia induces coronary vasodilation. The increased coronary flow with acute oxygen shortage has already been reported.
20 In our previous experimental studies with acute hypoxia, the coronary blood flow increased up to 600% of baseline values during the period of oxygen shortage, with a value remaining higher than that at baseline (>200%), even during the entire period of reoxygenation.
25 The effect of coronary vasodilation with hypoxia, probably mediated by nitric oxide release,
9,23,26 in the present model could have been exaggerated by the sudden decrease of the viscosity of coronary perfusion, which is more important in hypoxic polyglobulic than in normoxic hearts, because of our use of crystalloid solution for heart perfusion.
Myocardial metabolism
During the hypoxic baseline period, hearts extracted all the oxygen available, as from the very low venous PO2. Despite a similar performance, hearts recruited their anaerobic capacities to a different extent. The contribution of anaerobic mechanisms to total ATP turnover during the hypoxic baseline period, which was higher in hypoxic than in normoxic hearts, confirms that chronic hypoxia induces different degrees of hypoxic adaptation. In reoxygenated hearts lactate release was virtually undetectable, and therefore we speculated that hearts had to completely rely on aerobic metabolism. Lack of correlation between ATP turnover and performance indicates that the efficiency of energy production is different in the 2 groups because of increased activation of the mitochondrial KATP channels, probably the result of increased intracellular lactate,
27 or because of mitochondrial damage induced by reoxygenation.
28 Our data confirm the results of clinical studies on children with cyanotic congenital heart defects showing a direct correlation between the bioenergetics (ATP levels) and myocardial performance.
4,17
Limits of the model
One limit of our model is that animals entered the protocol at 5 weeks of age, whereas children with cyanotic congenital heart defects have generally been cyanotic since birth and have never been exposed to normoxia. It is true that the effect of normoxia for a certain period of time before chronic hypoxia has not yet been clarified. Nevertheless, it is well known to surgeons regularly involved with cyanotic congenital heart defects that in clinical practice there are examples of children with tetralogy of Fallot and with congenital heart defects with ductus-dependent pulmonary blood flow who are acyanotic at birth but become cyanotic later in life in correspondence, respectively, of the first hypoxic spell and of the ductal closure.
As a matter of fact, there are recent reports of experimental studies with pregnant guinea pigs
29 or rats
30 exposed to chronic hypoxia; unfortunately, the interpretation of the results provided by these studies must take into account the intermittent reoxygenation of the neonate animals when exposed to room air for feeding and maintenance, which is exactly what we wanted to avoid by creating our new system of hypoxic cages.
Another limit is the type of chronic hypoxia with environmental hypoxia. Other authors reported experimental studies using surgical models to induce central cyanosis, which is similar to the situation found with cyanotic children.
3,10,30 Certainly the surgical models used in dogs
3,10 or lambs
31 are not reproducible in a rat model.
| Conclusion |
|---|
|
|
|---|
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
Related Articles
This article has been cited by other articles:
![]() |
A. Caretti, P. Bianciardi, R. Ronchi, M. Fantacci, M. Guazzi, and M. Samaja Phosphodiesterase-5 Inhibition Abolishes Neuron Apoptosis Induced by Chronic Hypoxia Independently of Hypoxia-Inducible Factor-1{alpha} Signaling Exp Biol Med, October 1, 2008; 233(10): 1222 - 1230. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Khan, M. Birbach, M. S. Cohen, R. F. Ittenbach, T. L. Spray, R. J. Levy, and J. W. Gaynor Chronic Hypoxemia Increases Ventricular Brain Natriuretic Peptide Precursors in Neonatal Swine Ann. Thorac. Surg., February 1, 2008; 85(2): 618 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Corno Systemic venous drainage: can we help Newton? Eur. J. Cardiothorac. Surg., June 1, 2007; 31(6): 1044 - 1051. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Hickey, X. You, V. Kaimaktchiev, and R. M. Ungerleider Hypoxemic reperfusion exacerbates the neurological injury sustained during neonatal deep hypothermic circulatory arrest: a model of cyanotic surgical repair Eur. J. Cardiothorac. Surg., May 1, 2007; 31(5): 906 - 914. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fantacci, P. Bianciardi, A. Caretti, T. R. Coleman, A. Cerami, M. Brines, and M. Samaja Carbamylated erythropoietin ameliorates the metabolic stress induced in vivo by severe chronic hypoxia PNAS, November 14, 2006; 103(46): 17531 - 17536. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Draaisma, M. G. Hazekamp, N. Anes, P. H. Schoof, C. E. Hack, A. Sturk, and R. A.E. Dion Phosphorylcholine Coating of Bypass Systems Used for Young Infants Does Not Attenuate the Inflammatory Response Ann. Thorac. Surg., April 1, 2006; 81(4): 1455 - 1459. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L Schmitz, S. C Faulkner, C. E Johnson, J. L Tucker, M. Imamura, S B. Greenberg, and J. J Drummond-Webb Cardiopulmonary bypass for adults with congenital heart disease: pitfalls for perfusionists Perfusion, January 1, 2006; 21(1): 45 - 63. [Abstract] [PDF] |
||||
![]() |
D. A. Piel, A. R. Khan, R. Waibel, M. Birbach, M. S. Cohen, T. L. Spray, C. S. Deutschman, J. W. Gaynor, and R. J. Levy Chronic hypoxemia increases myocardial cytochrome oxidase J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 1101 - 1106. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Milano, P. Bianciardi, A. F. Corno, E. Raddatz, S. Morel, L. K. von Segesser, and M. Samaja Myocardial Impairment in Chronic Hypoxia Is Abolished by Short Aeration Episodes: Involvement of K+ATP Channels Exp Biol Med, December 1, 2004; 229(11): 1196 - 1205. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Corno, Y. Boone, I. Mallabiabarrena, M. Augstburger, P. Tozzi, E. Ferrari, and L. K. von Segesser Myocardial and pulmonary effects of aqueous oxygen with acute hypoxia Ann. Thorac. Surg., September 1, 2004; 78(3): 956 - 960. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Corno, Y. Boone, I. Mallabiabarrena, M. Augstburger, and L. K. von Segesser Aqueous oxygen: the solution to relief hypoxic pulmonary hypertension Eur. J. Cardiothorac. Surg., August 1, 2004; 26(2): 301 - 305. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Corno, G. Milano, S. Morel, P. Tozzi, C. Y. Genton, M. Samaja, and L. K. von Segesser Hypoxia: Unique myocardial morphology? J. Thorac. Cardiovasc. Surg., May 1, 2004; 127(5): 1301 - 1308. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Raff, J. J. Lee, E. P. Widmaier, M. K. Oaks, and W. C. Engeland Basal and Adrenocorticotropin-Stimulated Corticosterone in the Neonatal Rat Exposed to Hypoxia from Birth: Modulation by Chemical Sympathectomy Endocrinology, January 1, 2004; 145(1): 79 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Huddleston How do you study blue? J. Thorac. Cardiovasc. Surg., July 1, 2002; 124(1): 14 - 15. [Full Text] [PDF] |
||||
![]() |
B. S. Allen The reoxygenation injury: Is it clinically important? J. Thorac. Cardiovasc. Surg., July 1, 2002; 124(1): 16 - 19. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |